Stifel Maintains Buy on Insulet, Lowers Price Target to $225

Benzinga Newsdesk www.benzinga.com Negative 82.1%

Neg 82.1% Neu 0% Pos 0%

Stifel analyst Jonathan Block maintains Insulet (NASDAQ:PODD) with a Buy and lowers the price target from $250 to $225.

Comments

No comments yet. Be the first!